Biologic drug to treat anemia associated with chronic renal failure.
Palo Alto, CA
NASDAQ: AFFY
Investors 1
Date | Name | Website |
- | New Leaf V... | nlvpartner... |
Mentions in press and media 4
Date | Title | Description | Category | Author | Source |
13.10.2009 | Cincinnati... | Akebia is in a race to develop... | - | - | medcitynew... |
18.02.2009 | Public bio... | Much has been written about ho... | - | - | venturebea... |
10.05.2007 | Roundup: A... | Is the bell tolling for EPO? —... | - | - | venturebea... |
- | Cincinnati... | CINCINNATI, Ohio — As Procter ... | - | - | medcitynew... |